Supported by
Bulgarian Kidney Foundation
Medical University of Varna
| Cover and Content | |
| 1-8 |
| Parsabiv (etelcalcetide) - an allosteric modulator of the calcium-sensing receptor in hemodialysis patients with SHPT | |
| Snezhana Atanasova | 9-12 |
| Assisted Peritoneial Dialysis - Opportunity For Equal Access To Renal Replacement Therapy By Peritoneal Dialysis | |
| Rositsa Zortcheva, Darina Damyanova, Boryana Ivanova, Svetla Staykova | 13-16 |
| Biomarkers And Quality Of Life In Patients With Chronic Kidney Disease | |
| Svetla Staykova, Petar Petrov | 17-24 |
| Intradialytic Hypotension – Concept, Risk Factors And Clinical Consequences | |
| Snezhana Atanasova, Svetla Staykova, Dimitar Nenov | 25-31 |
| Pathophysiological Mechanisms Of Renal Disorders In Patients With β-Thalassemia Major | |
| Liliya Stoyanova | 32-36 |
| Reduction Of Proteinuria In Patients With Diabetes Mellitus Type 2 With Empagliflozin Treatment | |
| Anton Dinkov, Branimir Kanazirev | 37-39 |
| The Art of Communication… | |
| Miroslava Benkova-Petrova, Aleksandar Petrov, Svetla Staykova | 40-45 |
